Back to search

Typharm Limited

00894611

active
Private Limited Company
england wales
Companies House
Health Score
88 / 100

Healthy

30/30
Filing
20/30
Financial
38/40
Risk
  • 1 outstanding charge (-2)

Details

UNIT 1 39 MAHONEY GREEN, NORWICH, NR13 6JY
Incorporated 22/12/1966

Compliance

Last accounts

31/03/2025

total exemption full

Next accounts due

31/12/2026

On track

Confirmation statement

Last: 01/10/2025

Due 15/10/2026

On track

Industry

21100
Manufacture of basic pharmaceutical products

Officers

Mr Chandrakant Vallabhdas Ondhia Bsc(Hons) Pharm Mr Pharm Rpe Bc(Can)

director · Since 24/11/1997

PHARMACIST

BRITISH · UNITED KINGDOM · Age 72

Also on 17 other boards

Miss Amrisha Chandrakant Ondhia

director · Since 01/05/2018

DENTIST

BRITISH · ENGLAND · Age 33

Miss Chandni Chandrakant Ondhia

director · Since 01/05/2018

DOCTOR

BRITISH · ENGLAND · Age 40

Dr Deepesh Chandrakant Ondhia

director · Since 01/05/2018

DOCTOR

BRITISH · ENGLAND · Age 37

Also on 5 other boards

Persons with Significant Control

Mr Chandrakant Vallabhdas Ondhia

Significant control

British · United Kingdom · Age 72

Unit 1, 39 Mahoney Green, Norwich, NR13 6JY

Notified 06/04/2016

Typharm Developments Ltd

75–100% shares
75–100% votes
Appoint directors

Unit 39, Mahoney Green, Norwich, NR13 6JY

Reg: 08272004 · Companies House · Limited Company

Notified 07/07/2023

Charges1 outstanding

charge
outstanding

NATIONAL WESTMINSTER BANK PLC

Created 08/10/2002Registered 11/10/2002
charge
satisfied

NOVEX PHARMA LIMITED

Created 15/01/1999Registered 02/02/1999Satisfied 14/02/2001
charge
satisfied

STANDARD LIFE INVESTMENT FUNDS LIMITED

Created 29/05/1998Registered 05/06/1998Satisfied 26/01/2022
charge
satisfied

NATIONAL WESTMINSTER BANK LTD

Created 02/01/1981Registered 14/01/1981Satisfied 26/01/2022

CompanyRankvs 73+ SIC 21100 peers
74

Financial strength96th percentile among SIC peers · 24/25
Employees91th percentile among SIC peers · 14/15
LiquidityCurrent ratio 1.85× · 16/20
Longevity15 years trading (max 15) · 15/15
Filing complianceAll filings up to date · 15/15
Outstanding charges -10
Show leaderboard
1Lofthouse Of Fleetwood Limited
90
2West Pharmaceutical Services Cornwall Limited
90
3Dr. Reddy'S Laboratories (Eu) Limited
90
4Mw Encap Limited
90
5Rsr Limited
90
6Aura-Soma Products Limited
89
7Tcs Biosciences Limited
89
8Pharmapac (U.K.) Limited
89
9Onyx Scientific Limited
89
10International Scientific Supplies Limited
89
73Typharm Limited
80
How is this score calculated?
Financial strength24/25 pts

Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.

Employees14/15 pts

Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.

Liquidity16/20 pts

Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.

Longevity15/15 pts

One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.

Filing compliance15/15 pts

Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.

Risk deductions

Outstanding charges: -10 pts

Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.

Key FinancialsYear ending 31/03/2025

Net Worth

£8.3M

Balance sheet strength

Cash

£5.2M

Cash in the bank

Net Current Assets

£9.3M

Working capital

Current Assets

£20.2M

Current Liabilities

£10.9M

Fixed Assets

£68k

Debtors

£12.2M

13avg. employees+1

Balance Sheet

Assets less current liabilities£9.3M
Prepared with Sage Accounts Production Advanced 2023 - FRS102_2023

EstimatesDerived

YearCurrent RatioImplied Profit
20251.85-£236k
20241.82-£6.9M
20232.83+£2.0M
20222.83+£2.6M
20212.79—

Derived from filed accounts. Not audited figures.